Antazoline, Naphazoline

Vasocon A Eye Drops

5 MG / ML + .5 MG / ML DropsCanadaCancelledAuthorised 31 Dec 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Vasocon-AUnited States · 0.5%; 0.05% · solution/drops · NovartisSame brand
Optialerg 5 MG/ML + 0,25 MG/ML Colirio en SolucionSpain · 5,00 mg/ml + 0,25 mg/ml · colirio en solución · Laboratorios Cinfa S.A.Same substance
ALERGOFTAL 0,25 mg/ml+ 5 mg/ml COLIRIO EN SOLUCIONSpain · 0,25 mg + 5 mg · colirio en solución · Reva Health Europe S.L.Same substance
Apihist Eye\Nose DropSaudi Arabia · Amman Pharmaceutical Industries (API)Same substance
Nazolin Nasal DropsSaudi Arabia · Dar AldawaSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Antazoline, Naphazoline

Vasocon A Eye Drops

5 MG / ML + .5 MG / ML DropsCanadaCancelledAuthorised 31 Dec 1996

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NoscamSaudi Arabia · Riyadh Pharma

Antistin-Privin Eye DropsTaiwan · 點眼液劑 · 視康股份有限公司

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Antazoline, Naphazoline
Strength: 5 MG / ML + .5 MG / ML
Dosage form: Drops
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1996
Registration: DIN 02133369
Marketing authorisation holder: Novartis Ophthalmics Novartis Pharmaceuticals (Canada) INC
ATC code: S01GA51
Group: Sensory organs
Supply: NON-PRESCRIPTION DRUGS

Refresh Eye Allergy ReliefAntazoline + Naphazoline · 0.51 % + 0.051 % · SolutionCanadaCancelled

Steritears ArAntazoline + Naphazoline · 0.5 % + 0.05 % · DropsCanadaCancelled

Vasocon A Oph SolnAntazoline + Naphazoline · 5 MG / ML + .5 MG / ML · DropsCanadaCancelled